Search clinical trials for: GLP1 analogues

Total 512 results

Groupe Hospitalier Paris Saint Joseph

Recruiting

Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease (DiagMICI)

Diabetes Mellitus, Type 2 | Inflammatory Bowel Diseases

France
GlyPharma Therapeutics
VectivBio AG

Completed

Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency

SBS - Short Bowel Syndrome

Denmark
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

Obesity

United States
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Not yet recruiting

XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults

Obesity | Type 2 Diabetes Mellitus

Australia
GlyPharma Therapeutics
VectivBio AG

Completed

Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support

Short Bowel Syndrome

Denmark
Katarina Kos
University of Exeter

Terminated

Incretin and KATP Channels

Healthy Subjects

United Kingdom
The Affiliated Hospital of Xuzhou Medical University

Recruiting

Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM

Type 2 Diabetes Mellitus

China
Vanderbilt-Ingram Cancer Center

Recruiting

Finding the Cause for Post-Transplant Diabetes Mellitus After Allogeneic Hematopoietic Cell Transplant

Diabetes Mellitus | Cancer

United States
King Abdullah International Medical Research Center
Hoffmann-La Roche

Unknown

To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B (RC14/055)

Hepatitis B

Saudi Arabia
St Vincent's Hospital Melbourne
National Health and Medical Research Council, Australia

Unknown

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients (STOP)

Chronic Hepatitis B.

Australia
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

Lung Cancer

United States
Ipsen

Completed

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients (ANAREN)

Prostate Cancer

Spain
National Cancer Institute (NCI)

Terminated

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Limited Stage Small Cell Lung Cancer

United States
Nicola Frei

Not yet recruiting

Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis (PEP-PREPARE)

Post-ERCP Acute Pancreatitis

Switzerland
University Magna Graecia

Completed

CA 125 and VAS Pain Score Changes to Diagnose Endometriosis

Endometriosis | Pelvic Pain

Italy
Progen Pharmaceuticals
National Cancer Institute (NCI)

Completed

SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma

Lymphoma

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

United States
Christina Kruuse

Recruiting

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke (EGRABIS1)

Ischemic Stroke

Denmark
University Hospital, Ioannina
OTORHINOLARYNGOLOGY DEPARTMENT, UNIVERSITY GENERAL HOSPITAL OF IOANNINA; 1st...

Completed

EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY

Olfactory and Taste Dysfunction in SARS-CoV2 Infection

Greece
Mitsubishi Tanabe Pharma Corporation

Completed

Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
National Cancer Institute (NCI)

Completed

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) and other conditions

United States
Alexandria University

Recruiting

Effect of Protein Restriction Plus EAA/KA Supplementation on GFR Decline in CKD

Chronic Kidney Diseases

Egypt
Johns Hopkins University

Terminated

Glycemia in Diabetic Elders Trial

Type 2 Diabetes Mellitus

United States
Universitair Ziekenhuis Brussel

Not yet recruiting

Translation and Implementation of the Dutch VVAS Score in Clinical Practice

Vertigo
Oklahoma State University

Active, not recruiting

Longitudinal Examination of Metabolic and Behavioral Correlates of Protein Sources

Health Behavior

United States
Qingdao University
Qingdao Hiser Medical Group

Recruiting

Study of Hydrogen Inhalation Compared With Placebo in Type 2 Diabetes Patients

Type 2 Diabetes

China
Athenex, Inc.

Completed

Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies

Advance Malignancies

United States
Sun Yat-sen University

Not yet recruiting

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients

Breast Cancer

China
Christina Kruuse

Completed

The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers (EGRABINS1)

Stroke

Denmark
Istanbul Medipol University Hospital

Completed

Comparison of Different Pain Rating Scales in Patients With Symptomatic Teeth (CoPRS)

Pain | Dental Pain

Turkey
Allergan

Completed

An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments

Ocular Hypertension | Glaucoma, Open-Angle

Turkey
University of British Columbia
British Columbia Children's Hospital; Providence Health & Services

Completed

Evaluation of Smartphone Versions of VAS and NRS for Use in Adults (Panda)

Postoperative Pain

Canada
Mahidol University

Completed

Steatohepatitis in Chronic Hepatitis B

Fatty Liver | Chronic Hepatitis b

Thailand
Asan Foundation

Completed

Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism

Thromboembolism

Korea, Republic of
Arbutus Biopharma Corporation

Terminated

Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection

Chronic Hepatitis

Korea, Republic of, Hong Kong, Thailand, Canada, Australia, Moldova, Republic of, New Zealand, Ukraine
Arbutus Biopharma Corporation

Recruiting

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Chronic Hepatitis b

New Zealand
Vanderbilt University

Completed

Improving Hospitalizations for Children With ASD

Autism Spectrum Disorder | Autistic Disorder

United States
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Obesity

Australia
University of Houston

Recruiting

Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults

Smoking | Discrimination, Racial

United States
Centre Hospitalier Universitaire de Nice

Recruiting

Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (Maigrir_OT)

Obesity

France
Hospital de Clinicas de Porto Alegre

Unknown

Evaluation of Granulosa Cells Function After IVF Protocols

Infertility | In Vitro Fertilization Protocols

Brazil
Australasian Gastro-Intestinal Trials Group
Canadian Cancer Trials Group

Not yet recruiting

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (STOPNET)

Neuroendocrine Tumors

Australia
Third Affiliated Hospital, Sun Yat-Sen University
Peking University; First People's Hospital of Foshan; Shenzhen Third People's...

Unknown

The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

Chronic Hepatitis B

China
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants (XW003)

Obesity | Type 2 Diabetes Mellitus | Nonalcoholic Steatohepatitis

Australia
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Region Skane

Recruiting

Targeted Health Dialogues in Primary Care

Cardiovascular Diseases | Cancer | Risk Factors | Health Behaviors | Serious Diseases

Sweden
Hospices Civils de Lyon

Recruiting

Impact of Low Protein Diet Supplemented With Ketoanalogues Supplementation on Uremic Toxins Production (KETO-GUT)

Renal Failure

France
University of Zurich
Life Molecular Imaging SA

Terminated

Evaluation of a New Imagingtechnologie for Thrombosis (PET-GP1_1)

Deep Vein Thrombosis | Abdominal Aortic Aneurysm

Switzerland
University Magna Graecia

Completed

AMH Levels Change During Treatment With GnRh Agonist

Endometriosis | Pelvic Pain | Uterine Fibroids | Endometriosis of Uterus

Italy

Search clinical trials for: GLP1 analogues

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations